Prolactin and oxytocin: potential targets for migraine treatment

AK Szewczyk, S Ulutas, T Aktürk, L Al-Hassany… - The Journal of …, 2023 - Springer
Migraine is a severe neurovascular disorder of which the pathophysiology is not yet fully
understood. Besides the role of inflammatory mediators that interact with the …

Biosensors technology for anti-epileptic drugs

A Mobed, M Shirafkan, S Charsouei, J Sadeghzadeh… - Clinica Chimica …, 2022 - Elsevier
A broad group of antiepileptic drugs (AEDs) often controls the frequency of seizures. Given
the variability of pharmacokinetics, narrow target range, and the difficulty of identifying signs …

Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets

PA Castro, I Pinto-Borguero, GE Yévenes… - Frontiers in …, 2022 - frontiersin.org
The main strategy for the treatment of epilepsy is the use of pharmacological agents known
as antiseizure medication (ASM). These drugs control the seizure onset and improves the …

Temporal relationship between levetiracetam nonadherence and breakthrough seizures in a preclinical model of temporal lobe epilepsy

M Guignet, J Vuong, A Martinez, T Ballapapinan… - …, 2024 - Wiley Online Library
Objective Poor medication adherence remains a concern for individuals managing their
epilepsy with antiseizure medicines (ASMs); however, ethical concerns around withholding …

N-type Ca channel in epileptic syndromes and epilepsy: A systematic review of its genetic variants

S Mayo, I Gomez-Manjon… - International journal of …, 2023 - mdpi.com
N-type voltage-gated calcium channel controls the release of neurotransmitters from
neurons. The association of other voltage-gated calcium channels with epilepsy is well …

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug‐resistant focal seizures

M Carreño, A Gil‐Nagel, JM Serratosa… - Epilepsia …, 2024 - Wiley Online Library
Objective Cenobamate is an antiseizure medication (ASM) associated with high rates of
seizure freedom and acceptable tolerability in patients with focal seizures. To achieve the …

Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy

V Vashi, WE Rosenfeld, L Ferrari, M Kamin - Epilepsy Research, 2023 - Elsevier
Objective Cenobamate was approved by the US Food and Drug Administration (FDA) based
on studies of adjunctive therapy in patients with focal epilepsy. To support the use of …

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy

JQ Yi, S Huang, MJ Wu, JH Ma, LJ Huang… - Frontiers in …, 2023 - frontiersin.org
Objective: This study aims to compare the effectiveness and safety of perampanel and
oxcarbazepine as monotherapy in children with focal epilepsy (FE). Methods: This is an …

An update on the novel methods for the discovery of antiseizure and antiepileptogenic medications: where are we in 2024?

A Talevi, C Bellera - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Despite the availability of around 30 antiseizure medications, 1/3 of patients
with epilepsy fail to become seizure-free upon pharmacological treatment. Available …

Introduction to therapeutic drug monitoring: Frequently and less frequently monitored drugs

A Dasgupta - Therapeutic drug monitoring, 2024 - Elsevier
Therapeutic drug monitoring is useful for individual dosage adjustment and avoiding drug
toxicity for certain drugs with narrow therapeutic window. However, only relatively few drugs …